NCR1 and neoplasm: Other metalloproteinases, such as ADAM9, were upregulated after tumor recognition and may play a similar role in downregulating the expression of other NK cell receptors, such as NKG2D or NKp46 and promoting NK cell survival and serial engagement with targets [40].